Active Pharmaceutical Ingredient (API)
Efavirenz
Non-Nucleoside Reverse Transcriptase Inhibitor ($\text{NNRTI}$)
A Non-Nucleoside Reverse Transcriptase Inhibitor ($\text{NNRTI}$) used in combination with other agents for the treatment of $\text{HIV-1}$ infection. It non-competitively inhibits the enzyme Reverse Transcriptase, blocking the conversion of viral $\text{RNA}$ to $\text{DNA}$. It is a key component of many $\text{first-line ART}$ (Antiretroviral Therapy) regimens in India.
Technical Profile
- Reference Code
- EFA364
- CAS Number
- 154598-52-4
- Chemical Class
- N/A
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Efavirenz as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| Trioday H | Cipla Limited | Tablet (600 mg) | ₹1,850.00 | View Details |
| Viraday H | Cipla Limited | Tablet (600 mg) | ₹4,866.46 | View Details |